Bill Text: NJ A4325 | 2024-2025 | Regular Session | Introduced
Bill Title: Permits procurement of medical countermeasures, products, and therapeutics.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Introduced) 2024-06-03 - Reported and Referred to Assembly Appropriations Committee [A4325 Detail]
Download: New_Jersey-2024-A4325-Introduced.html
Sponsored by:
Assemblyman HERB CONAWAY, JR.
District 7 (Burlington)
SYNOPSIS
Permits procurement of medical countermeasures, products, and therapeutics.
CURRENT VERSION OF TEXT
As introduced.
An Act concerning the procurement of medical countermeasures and supplementing Title 26 of the Revised Statutes.
Be It Enacted by the Senate and General Assembly of the State of New Jersey:
1. a. Notwithstanding the provisions of P.L.1954, c.48 (C.52:34-6 et seq.), R.S.52:25-1 et seq., or any other law to the contrary, the Department of Health may directly purchase medical countermeasures, supplies, and therapeutics pursuant to any federal laws, regulations, or programs, in accordance with the terms and conditions set forth in a contract that has been approved by the federal department or agency responsible for administering such laws, regulations, or programs, if the Commissioner of Health determines that the purchase is necessary to advance or protect public health and safety.
b. Notwithstanding any provisions of the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), to the contrary, the Commissioner of Health may adopt, immediately upon filing with the Office of Administrative Law, regulations that the Commissioner of Health deems necessary to effectuate the purposes of this act, which regulations shall be effective for a period not to exceed 18 months from the date of the filing. The Commissioner of Health may thereafter amend, adopt, or readopt the regulations in accordance with the requirements of P.L.1968, c.410 (C.52:14B-1 et seq.).
2. This act shall take effect immediately.
STATEMENT
This bill permits the procurement of medical countermeasures, products, and therapeutics.
Under the bill, the Department of Health may directly purchase medical countermeasures, supplies, and therapeutics pursuant to any federal laws, regulations, or programs, in accordance with the terms and conditions set forth in a contract that has been approved by the federal department or agency responsible for administering such laws, regulations, or programs, if the Commissioner of Health determines that the purchase is necessary to advance or protect public health and safety.
